Abstract

The rate of disappearance of antipyrine from the plasma is a useful indicator for the in vivo capacity for hepatic mixed function oxidation. The short term effects of systemic administration of dexamethasone, a potent glucocorticoid, and ACTH on antipyrine metabolism were studied in 10 children. Dexamethasone (2 mg/d × 4 days) was given to 6 subjects. The effects of ACTH (40 U/24 h i.v. × 5 days) were evaluated in 4 patients. The half-life of antipyrine (t½) was measured before and after drug therapy in each patient. The mean t½ was not affected by administration of dexamethasone (t½ 7.6 ± 1.14 h versus 7.8 ± 0.84 h). The apparent volume of distribution (aVd) remained unchanged as well (aVd 0.52 ± 0.076 L/kg versus 0.56 ± 0.063 L/kg). Administration of ACTH, causing a 5-25 fold increase in urinary 17-hydroxy-corticosteroid excretion, also did not affect the half-life of antipyrine (t½ 11.5 ± 2.8 h versus 11.2 ± 2 h). The aVd also remained unchanged (0.60 ± 0.05 L/kg versus 0.59 ± 0.03 L/kg). We conclude that the short term administration of dexamethasone and ACTH with ensuing stimulation of endogenous glucocorticoid production is unlikely to produce clinically significant changes in the rate of drug metabolism.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call